Mahindra Group led Mahindra Lifespaces has purchased 12,000 sq m plot from Nycomed Pharma Private limited for around R205 Cr, according to TOI.
The plot located at Andheri, currently houses a bungalow, two guest houses, a R&D facility and an electric sub-station.
The plot has a development potential of 5 lakh sq ft under the new building planning rules framed by the civic body. Mahindra is planning to set up a high-end residential complex on the plot.
Nycomed Pharma was Nycomed A/S (Switzerland) 100% subsidiary in India. Established in 2003, the company constitutes Nycomed's only global R&D centre outside of Europe.
In 2011, Japanese pharma major – Takeda Global acquired Nycomed A/S for 9.6 Bn euros.
Incorporated in 1999 as Gesco Corporation, Mahindra Lifespaces has two major business segments – residential development and integrated business cities. The company is executing two integrated business city projects in Chennai and Jaipur through its subsidiaries – Mahindra World City Developers Limited and, respectively. M&M held 51% stake in MLDL as on March 31, 2012.
Hyderabad-based CVR Group unit Navayuga Power may sell stake in its power assets to Toshiba, Sumitomo, Mitsubishi & GDF Suez. The deal Value expected to be in between INR 13,800 to 14,400 Mn for equity stake 49 to 51%.
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.